Press Releases
Financial
Archive
Industry Events
Home


Investor & Media
Relations Contact
Michael Watts
Vice President, Investor Relations and Corporate Communications
10210 Genetic Center Drive
San Diego, CA 92121
Tel: (858) 410-8673
michaelw@gen-probe.com





Date   Title
07/29/10 Printer Friendly Version Gen-Probe Reports Financial Results for the Second Quarter of 2010
07/13/10 Printer Friendly Version Gen-Probe Announces Webcast of Second Quarter 2010 Earnings Conference Call
06/30/10 Printer Friendly Version Gen-Probe Receives European CE Mark for Molecular Test to Detect Common Sexually Transmitted Disease Trichomonas Vaginalis
06/17/10 Printer Friendly Version Gen-Probe Makes $50 Million Strategic Investment in Third Generation Sequencing Company Pacific Biosciences
04/29/10 Printer Friendly Version Gen-Probe Reports Financial Results for the First Quarter of 2010
04/27/10 Printer Friendly Version Gen-Probe to Webcast Two Upcoming Investor Presentations
04/22/10 Printer Friendly Version PROGENSAŽ PCA3 Assay Can Help Predict Outcome of Initial Prostate Biopsies, According to Study Presented at Leading Urology Meeting
04/08/10 Printer Friendly Version Gen-Probe Announces Webcast of First Quarter 2010 Earnings Conference Call
03/22/10 Printer Friendly Version Brian McNamee Elected to Gen-Probe Board of Directors
03/08/10 Printer Friendly Version PROGENSAŽ PCA3 Assay Can Help Guide Repeat Prostate Biopsy Decisions, Data Presented at Leading Medical Meeting Confirm


Gen-Probe Incorporated
10210 Genetic Center Drive
San Diego, CA 92121

Map  |  Terms  |  Privacy  |  Help